Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2025

Mar 12, 2025

3535_rns_2025-03-12_b3f0794a-c3a8-4b39-aa1f-09e51f91724a.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Aqua Bio Technology ASA – Ex. date for Subsequent Offering today

12.3.2025 08:49:25 CET | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state

Reference is made to the announcement by Aqua Bio Technology ASA on 11 March 2025 concerning the successful placement of the conditional private placement with total gross proceeds of approximately NOK 24.2 million, and a contemplated subsequent offering (the "Subsequent Offering"), and to the announcement with key information for the Subsequent Offering.

The shares in Aqua Bio Technology ASA will be traded exclusive of the right to receive subscription rights in the Subsequent Offering as of today, 12 March 2025.

This information is published in accordance with the requirements of the Continuing Obligations in Euronext Rule Book II.

Disclosure regulation

This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.

Contacts

Fredrik Henriksen, CEO, Aqua Bio Technology ASA, +47 90 02 00 78, [email protected]

About Aqua Bio Technology ASA

Aqua Bio Technology ASA (ABT) is a distribution group in skincare and nonfood. The group has distribution towards B2C, B2B, B2B2, and freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange.

Attachments

Download announcement as PDF.pdf